Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;28(1):81-5.
doi: 10.1097/MOP.0000000000000305.

Advances in the prevention and treatment of congenital cytomegalovirus infection

Scott H James  1 , David W Kimberlin
Affiliations
Review

Advances in the prevention and treatment of congenital cytomegalovirus infection

Scott H James et al. Curr Opin Pediatr. 2016 Feb.

Abstract

Purpose of review: Cytomegalovirus (CMV) is the most common cause of congenital infection in the world. Symptomatic infants are at increased risk of developing permanent sequelae, including sensorineural hearing loss and neurodevelopmental delay. Advances in the treatment and prevention of congenital CMV infection are a high priority nationally and globally.

Recent findings: In symptomatic infants, antiviral therapy with 6 months of oral valganciclovir improves hearing and neurodevelopmental outcomes. Strategies to prevent congenital or maternal CMV infections, including the use of CMV hyperimmune globulin and development of a maternal vaccine, have yet to yield positive results.

Summary: The clinical significance of congenital CMV infection, developments in antiviral therapy, and efforts to prevent congenital disease are herein reviewed.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253–76. - PubMed
    1. Manicklal S, Emery VC, Lazzarotto T, et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86–102. - PMC - PubMed
    1. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–13. - PubMed
    1. Stadler LP, Bernstein DI, Callahan ST, et al. Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females. Journal of the Pediatric Infectious Diseases Society. 2013;2(1):7–14. - PMC - PubMed
    1. Boppana SB, Rivera LB, Fowler KB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001;344(18):1366–71. - PubMed

Publication types

MeSH terms